Systemic proteolytic enzyme treatment diminishes urinary interleukin 6 in diabetic patients.
Paczek
L
L
Kropiewnicka
E H
EH
Bartlomiejczyk
I
I
Gradowska
L
L
Heidland
A
A
Wood
G
G
D000368:Aged; D001963:Bromelains / Q000627:therapeutic use*; D003922:Diabetes Mellitus, Type 1 / Q000097:blood / Q000188:drug therapy* / Q000652:urine; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D015850:Interleukin-6 / Q000097:blood / Q000652:urine*; D008297:Male; D008875:Middle Aged; D010447:Peptide Hydrolases / Q000627:therapeutic use*; D012431:Rutin / Q000031:analogs & derivatives* / Q000627:therapeutic use; D014357:Trypsin / Q000627:therapeutic use*
D015850:Interleukin-6; C056067:rutin sulfate; D012431:Rutin; D001963:Bromelains; D010447:Peptide Hydrolases; D014357:Trypsin